[1]TARANTINO G,FINELLI C.Pathogenesis of hepatic steatosis:the link between hypercortisolism and non-alcoholic fatty liver disease[J].World J Gastroenterol,2013,19(40):6735-6743.
|
[2]BEGRICHE K,MASSART J,ROBIN MA,et al.Drug-induced toxicity on mitochondria and lipid metabolism:mechanistic diversity and deleterious consequences for the liver[J].J Hepatol,2011,54(4):773-794.
|
[3]PAIS R,RUSU E,RATZIU V.The impact of obesity and metabolic syndrome on chronic hepatitis B and drug-induced liver disease[J].Clin Liver Dis,2014,18(1):165-178.
|
[4]LEE SS,PARK SH.Radiologic evaluation of nonalcoholic fatty liver disease[J].World J Gastroenterol,2014,20(23):7392-7402.
|
[5]PICKHARDT PJ,PARK SH,HAHN L,et al.Specificity of unenhanced CT for non-invasive diagnosis of hepatic steatosis:implications for the investigation of the natural history of incidental steatosis[J].Eur Radiol,2012,22(5):1075-1082.
|
[6]LEE SW,PARK SH,KIM KW,et al.Unenhanced CT for assessment of macrovesicular hepatic steatosis in living liver donors:comparison of visual grading with liver attenuation index[J].Radiology,2007,244(2):479-485.
|
[7]SCHWENZER NF,SPRINGER F,SCHRAML C,et al.Non-invasive assessment and quantification of liver steatosis by ultrasound,computed tomography and magnetic resonance[J].J Hepatol,2009,51(3):433-445.
|